NCT04198766
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04198766
Title Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Inhibrx Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Los Angeles Cancer Network Glendale California 91204 United States Details
California Research Institute Los Angeles California 90027 United States Details
Valkyrie Clinical Trials Los Angeles California 90069 United States Details
Valkyrie Clinical Trials Murrieta California 92562 United States Details
Providence Medical Foundation Santa Rosa California 95403 United States Details
Clermont Oncology Center Clermont Florida 34711 United States Details
Mid Florida Hematology and Oncology Center Orange City Florida 32763 United States Details
Winship Cancer Institute - Emory University Atlanta Georgia 30322 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
University of Iowa Iowa City Iowa 52242 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Henry Ford Cancer Institute Detroit Michigan 48202 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
HealthPartners Cancer Research Center Saint Louis Park Minnesota 55426 United States Details
HealthPartners Cancer Research Center (Regions Hospital) Saint Paul Minnesota 55101 United States Details
Intermountain Health Cancer Centers of Montana Billings Montana 59102 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
Montefiore Medical Center The Bronx New York 10467 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Vanderbilt University School of Medicine Nashville Tennessee 37204 United States Details
Sarah Cannon Research Institute at Mary Crowley Dallas Texas 75230 United States Details
Renovatio Clinical - El Paso El Paso Texas 79915 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
Renovatio Clinical The Woodlands Texas 77380 United States Details
The University of Texas Health Science Center at Tyler Tyler Texas 75701 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Curie Oncology Singapore Singapore Details
Icon Cancer Centre Farrer Park Singapore Singapore Details
Icon Cancer Centre Mount Alvernia Singapore Singapore Details
The Catholic University of Korea, St. Vincent's Hospital Gyeonggi-do South Korea Details
Asan Medical Center Seoul South Korea Details
Severance Hospital, Yonsei University Health System Seoul South Korea Details
The Catholic University of Korea Seoul St. Mary's Hospital, Seoul South Korea Details
Changhua Christian Hospital (CCH) Changhua Taiwan Details
E-Da Cancer Hospital Kaohsiung City Taiwan Details
Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) Kaohsiung City Taiwan Details
National Cheng Kung University Hospital Tainan Taiwan Details
Taipei Veterans General Hospital Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field